Skip to content
OpenCapital
Get started

Travere Therapeutics, Inc. TVTX Other Research And Development Expense

Other Research And Development Expense at other companies

Celanese Corporation logo
Celanese CorporationCE
$0—
TG Therapeutics logo
TG TherapeuticsTGTX
$43.52M+1.1%
Teradyne, Inc. logo
Teradyne, Inc.TER
$135.56M+14.7%
ACI Worldwide logo
ACI WorldwideACIW
$44.09M+13.3%
Globus Medical logo
Globus MedicalGMED
$9.17M+20.2%
Monolithic Power Systems logo
Monolithic Power SystemsMPWR
$100.57M+9.0%

Segments

By segment

See full
Reportable Segment$4.84M+9.2%

Other financials

Income statement

See full
Revenue$127.2M+55.6%
Gross profit$125.2M+62.5%
Operating income-$36.9M+13.5%
Net income-$37.1M+10.0%
EPS (diluted)-$0.40+14.9%

Balance sheet

See full
Cash & equivalents$78.4M+26.6%
Total debt$15.6M-82.6%
Total equity$98.7M+201%
Total assets$555.2M+1.2%

Cash flow

See full
Operating cash flow-$40.4M+4.3%
CapEx$140.0K—
Free cash flow-$42.5M+28.1%

Valuation

See full
Market cap$5.13B+72.3%
Enterprise value$5.07B+65.5%
P/S9.6×-1.3×

Profitability

See full
Gross margin98.6%+2.6pp
Operating margin-10.6%-5.0pp
Net margin-20.3%-9.5pp
FCF margin-133.9%-34.4pp

Returns & leverage

See full
Return on equity-706%-1,302pp
Debt / equity0.2×-2.6×
Current ratio3.1×+1.1×